
|Articles|August 16, 2018
Risuteganib for the treatment of DME
Advertisement
Peter Kaiser, MD, shares how risuteganib (Luminate, Allegro) can help with the treatment of DME when anti-VEGF treatment isn't a viable option. He presented his research in Vancouver, British Columbia, during the 2018 annual meeting of the American Society of Retina Specialists.
Advertisement
Latest CME
Advertisement
Advertisement


















